RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TURCO F
Collezione ASL Torino 4

Items : 14

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
AO Cuneo
ASL Cuneo 2
AO Ordine Mauriziano
ASL Torino 4
AOU San Luigi di Orbassano

Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M; Reale ML; Trastu F; Paratore C; Marandino L; Mariniello A; Lombardi P; Ghisoni E; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Rossi A; Aimar G; Audisio M;

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.

2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Parlagreco E; Audisio A; Audisio M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Tucci M; Turco F;

Prostate Cancer and Sleep Disorders: A Systematic Review. in Cancers / Cancers (Basel). 2022 Mar 31;14(7):1784. doi: 10.3390/cancers14071784.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Mangan D; Turco F; Ottaviano M; Treglia G; Marandino L; Manconi M; Pereira-Mestre R; Rossi L; Napoli I; Sparasci D; Gillessen S; Vogl UM;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;

Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11. in European urology / Eur Urol. 2022 Jul;82(1):e13. doi: 10.1016/j.eururo.2022.03.029. Epub 2022 Mar 28.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Gillessen S; Smith M; Omlin A; Turco F;

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. in European urology / Eur Urol. 2022 Jul;82(1):6-11. doi: 10.1016/j.eururo.2022.02.010. Epub 2022 Feb 17.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Sydes M; Sweeney C; Suzuki H; Sternberg CN; Spratt D; Smith M; Soule H; Small E; Shore N; Skoneczna I; Scher HI; Sartor O; Pablo Sade J; Saad F; Ryan CJ; Rubin M; Reiter RE; Rathkopf D; Rabah DM; Pritchard CC; Parker C; Poon DMC; Padhani AR; O'Sullivan JM; Ost P; Ekeke Onyeanunam N; Oh WK; Murthy V; Morris MJ; et alii...

Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11]. in European urology / Eur Urol. 2022 Jul;82(1):e18-e19. doi: 10.1016/j.eururo.2022.04.004. Epub 2022 Apr 16.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Taplin ME; Sydes M; Sweeney C; Suzuki H; Spratt D; Sternberg CN; Soule H; Smith M; Small E; Skoneczna I; Shore N; Scher HI; Sartor O; Sade JP; Ryan CJ; Saad F; Reiter RE; Rubin M; Rathkopf D; Rabah DM; Pritchard CC; Parker C; Poon DMC; Padhani AR; O'Sullivan JM; Ost P; Ekeke ON; Murthy V; Oh WK; et alii...

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond. in Cells / Cells. 2022 Jan 21;11(3):357. doi: 10.3390/cells11030357.

2022
ASL Asti
ASL Torino 4
AOU San Luigi di Orbassano

Tucci M; Di Prima L; Turco F; Di Stefano RF; Ungaro A; Audisio M; Parlagreco E; Delcuratolo MD; Audisio A; Buttigliero C;

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Delcuratolo MD; Ungaro A; Buttigliero C; Di Maio M; Audisio A; Di Prima L; Turco F; Scagliotti GV; Pisano C; Tucci M;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;

2022
ASL Torino 4

Omlin A; Gillessen S; Smith M; Turco F;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough? in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):870-872. doi: 10.23736/S2724-6051.21.04817-5.

2021
ASL Asti
ASL Torino 4
AOU San Luigi di Orbassano

Tucci M; Turco F; Buttigliero C;